Literature DB >> 9690912

Development of approximate formula for LDL-chol, LDL-apo B and LDL-chol/LDL-apo B as indices of hyperapobetalipoproteinemia and small dense LDL.

Y Hattori1, M Suzuki, M Tsushima, M Yoshida, Y Tokunaga, Y Wang, D Zhao, M Takeuchi, Y Hara, K I Ryomoto, M Ikebuchi, H Kishioka, T Mannami, S Baba, Y Harano.   

Abstract

Estimation of LDL-chol and LDL-apo B is useful for the diagnosis of hyperapobetalipoproteinemia (normal LDL-chol with increased LDL-apo B), which is one of the most commonly occurring lipoprotein disorders associated with atherosclerotic cardiovascular diseases. The LDL-chol/LDL-apo B ratio reflects the level of small dense LDL, which is an important risk factor for IHD, CVD and ASO. In order to estimate LDL-apo B and LDL-chol/LDL-apo B ratio from blood chol, TG, HDL-chol and apo B values, we developed a formula for LDL-chol ¿0.94Chol- 0.94HDL-chol - 0.19TG¿, LDL-apo B ¿apo B - 0.09Chol + 0.09HDL-chol-0.08TG¿, and LDL-chol/LDL-apo B [¿0.94Chol-0.94HDL-chol - 0.19TG¿/¿apo B - 0.09Chol + 0.09HDL-chol-0.08TG¿] using ultracentrifugal data from 2179 subjects. These were calculated by the least squares method on the assumption that a certain compositional relationship exists between Chol, TG and apo B in VLDL, IDL and LDL. Friedewald's formula for LDL-chol (Chol - HDL-chol - 0.2TG) includes IDL-chol, but the present new formula theoretically excludes IDL-chol. It suggests a better estimation for the correct LDL-chol. Estimated LDL-apo B is useful for the diagnosis of hyperapobetalipoproteinemia and detection of small dense LDL. Without performing ultracentrifuge, additional information is obtained for the quantitative and qualitative alteration of LDL, such as small dense LDL. The above formulae and a new classification of lipoproteinemia including apo B were applied to the analyses of lipoprotein profiles of subjects with cardiovascular diseases, which were compared with those in the general population. Hyperapobetalipoproteinemia with high TG was observed 2-3 times more frequently in subjects with CAD, MI and ASO than in the Suita population. Lower ratios of LDL-chol/LDL-apo B, reflecting preponderance of small dense LDL, were observed in the above three groups. Type IIb and combined low HDL-chol were also frequent phenotypes in CAD, A-Th and ASO. The present formulae are useful for the detailed analyses of lipoprotein disorders in both qualitative as well as quantitative aspects.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9690912     DOI: 10.1016/s0021-9150(98)00034-3

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  26 in total

1.  Ciprofibrate increases paraoxonase activity in patients with metabolic syndrome.

Authors:  György Paragh; Ildikó Seres; Mariann Harangi; Annamária Erdei; Mária Audikovszky; Lóránd Debreczeni; Anna Kovácsay; László Illyés; Gyula Pados
Journal:  Br J Clin Pharmacol       Date:  2006-06       Impact factor: 4.335

2.  A modified formula for calculating low-density lipoprotein cholesterol values.

Authors:  Yunqin Chen; Xiaojin Zhang; Baishen Pan; Xuejuan Jin; Haili Yao; Bin Chen; Yunzeng Zou; Junbo Ge; Haozhu Chen
Journal:  Lipids Health Dis       Date:  2010-05-21       Impact factor: 3.876

3.  Triglyceride metabolism in Japanese kidney transplant recipients.

Authors:  Makoto Tsujita; Norihiko Goto; Kenta Futamura; Manabu Okada; Takahisa Hiramitsu; Syunji Narumi; Yoshihiko Watarai
Journal:  Clin Exp Nephrol       Date:  2017-08-28       Impact factor: 2.801

4.  Measured Versus Calculated Small Dense LDL-Cholesterol and Cardiometabolic Traits in a South African Population.

Authors:  M Masoud; A P Kengne; R T Erasmus; G M Hon; M Macharia; T E Matsha
Journal:  Indian J Clin Biochem       Date:  2018-03-22

5.  Evaluation of different formulas for LDL-C calculation.

Authors:  Ana Vujovic; Jelena Kotur-Stevuljevic; Slavica Spasic; Nada Bujisic; Jelena Martinovic; Milica Vujovic; Vesna Spasojevic-Kalimanovska; Aleksandra Zeljkovic; Dragoljub Pajic
Journal:  Lipids Health Dis       Date:  2010-03-10       Impact factor: 3.876

6.  Association of Iron Overload with Oxidative Stress, Hepatic Damage and Dyslipidemia in Transfusion-Dependent β-Thalassemia/HbE Patients.

Authors:  Chintana Sengsuk; Orathai Tangvarasittichai; Prasert Chantanaskulwong; Ampai Pimanprom; Somsak Wantaneeyawong; Anuchit Choowet; Surapon Tangvarasittichai
Journal:  Indian J Clin Biochem       Date:  2013-08-29

7.  A Study of the Extended Lipid Profile including Oxidized LDL, Small Dense LDL, Lipoprotein (a) and Apolipoproteins in the Assessment of Cardiovascular Risk in Hypothyroid Patients.

Authors:  Sanjiv Kumar Bansal; Rakhee Yadav
Journal:  J Clin Diagn Res       Date:  2016-06-01

8.  Effects of a new low dose soy protein/beta-sitosterol association on plasma lipid levels and oxidation.

Authors:  Arrigo F G Cicero; Monica Minardi; Sifa Mirembe; Egidio Pedro; Antonio Gaddi
Journal:  Eur J Nutr       Date:  2004-01-26       Impact factor: 5.614

9.  Conventional and Advanced Lipid Parameters in Premature Coronary Artery Disease Patients in India.

Authors:  Sanjiv Kumar Bansal; Sarita Agarwal; Mridul Kumar Daga
Journal:  J Clin Diagn Res       Date:  2015-11-01

10.  New modified Friedewald formulae for estimating low-density lipoprotein cholesterol according to triglyceride levels: extraction and validation.

Authors:  Asghar Ghasemi; Samaneh Asgari; Farzad Hadaegh; Masoumeh Kheirandish; Iraj Azimzadeh; Fereidoun Azizi; Maryam Tohidi
Journal:  Endocrine       Date:  2018-07-24       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.